FierceBiotech 5 déc. 2025 Praxis claims efficacy success in phase 2 seizure trial, setting up approval talks with FDA
FierceBiotech 5 déc. 2025 Pfizer Ventures gets behind Chinese biotech's $100M series A to boost R&D hub's capability
FierceBiotech 4 déc. 2025 GE HealthCare, Mayo Clinic launch digital twin project for personalizing radiation cancer therapy
FierceBiotech 4 déc. 2025 Paradigm Health raises $78M to revamp clinical research process, inks deal with Roche’s Flatiron
FierceBiotech 4 déc. 2025 After dodging Biosecure threat, WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg
FierceBiotech 4 déc. 2025 Crescent waxes pipeline with $80M Kelun deal, bagging ADC to pair with PD-1xVEGF bispecific
FierceBiotech 4 déc. 2025 Royalty pens $275M financing deal for Denali drug awaiting delayed FDA decision
FierceBiotech 4 déc. 2025 After more than 20 years, Medtronic claims deep brain stimulation approval for dystonia
FierceBiotech 4 déc. 2025 A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes
FierceBiotech 4 déc. 2025 FDA names Tracy Beth Høeg, fresh from vaccine safety probe, as acting head of drug center
FierceBiotech 4 déc. 2025 FDA floats user fee cuts for early-stage US trials, additional fees for overseas development
FierceBiotech 3 déc. 2025 Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy